Synaffix B.V.: Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ...
AMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025 /PRNewswire/ -- Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing ...
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology
Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage ...
FierceBiotech2 小时
Lonza's Synaffix adds Boehringer to its constellation of partners with $1.3B ADC tech pact
After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking ...
Cardiac Arrhythmia Monitoring Devices Market To Register Incremental Growth At A CAGR Of ...
Key Takeaways from the Cardiac Arrhythmia Monitoring Devices Market Report .On November 13, 2024, SmartCardia received FDA clearance for its Mobile Outpatient Cardiac Telemetry (OCT/MCT) system, which ...